Metabolism correctors in patients with comorbid pathology
Acute alcohol-associated conditions are diagnosed in 60% of emergency patients and include a combination of acute ethanol (or its counterfeit) intoxication and the abstinence syndrome (Vertkin et al., 2009). Mildronat® added to a standard therapy of acute alcohol-associated conditions is highly beneficial in the treatment of surgical patients with comorbid pathology. Metabolism corrector Mildronat® serves as an essential supplement to the basic therapy of comorbid pathology which by far makes its clinical use highly promising.